EP4591905A1 — Electronic add-on module and assembly of an electronic add-on module and a drug delivery device
Assigned to Sanofi SA · Expires 2025-07-30 · 1y expired
What this patent protects
The present disclosure is directed to an electronic add-on module (100) configured for attachment to a drug delivery device and to an assembly comprising a drug delivery device and an electronic add-on module (100). The electronic add-on module may comprise a first portion (101) …
USPTO Abstract
The present disclosure is directed to an electronic add-on module (100) configured for attachment to a drug delivery device and to an assembly comprising a drug delivery device and an electronic add-on module (100). The electronic add-on module may comprise a first portion (101) with a main housing (103) defining a longitudinal axis (X). The module (100) comprises a gripping mechanism allowing attachment to drug delivery device dose dial user interfaces, e.g. a dial grip (G, G'), and/or drug delivery device injection user interfaces, e.g. a dose button (B, B') of varying diameters and shapes. The first portion (101) comprises on an inner side of the main housing (103) at least two elastically deformable arms (118) each having a clamping section (121) which is configured to be elastically, deflected radially outwards with respect to the longitudinal axis (X) from a unstressed, nominal position to a strained deflected position.
Drugs covered by this patent
- Ozempic (semaglutide) · Novo Nordisk
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.